Cite
HARVARD Citation
Micha, J. et al. (2007). A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. International journal of gynecological cancer. 17 (4), pp. 771-776. [Online].